Residual microglia following short‐term PLX5622 treatment in 5xFAD mice exhibit diminished NLRP3 inflammasome and mTOR signaling, and enhanced autophagy.

MLA

Kodali, Maheedhar, et al. “Residual Microglia Following Short‐term PLX5622 Treatment in 5xFAD Mice Exhibit Diminished NLRP3 Inflammasome and MTOR Signaling, and Enhanced Autophagy.” Aging Cell, Nov. 2024, p. 1. EBSCOhost, https://doi.org/10.1111/acel.14398.

APA

Kodali, M., Madhu, L. N., Somayaji, Y., Attaluri, S., Huard, C., Panda, P. K., Shankar, G., Rao, S., Shuai, B., Gonzalez, J. J., Oake, C., Hering, C., Babu, R. S., Kotian, S., & Shetty, A. K. (2024). Residual microglia following short‐term PLX5622 treatment in 5xFAD mice exhibit diminished NLRP3 inflammasome and mTOR signaling, and enhanced autophagy. Aging Cell, 1. https://doi.org/10.1111/acel.14398

Chicago

Kodali, Maheedhar, Leelavathi N. Madhu, Yogish Somayaji, Sahithi Attaluri, Charles Huard, Prashanta Kumar Panda, Goutham Shankar, et al. 2024. “Residual Microglia Following Short‐term PLX5622 Treatment in 5xFAD Mice Exhibit Diminished NLRP3 Inflammasome and MTOR Signaling, and Enhanced Autophagy.” Aging Cell, November, 1. doi:10.1111/acel.14398.